TOBINintel · Condition

PCOS & Hormonal Dysregulation

PCOS is approached as a metabolic–endocrine phenotype: androgen and insulin signaling, adipose inflammation, nutrient status and endocrine-active exposures are evaluated side by side.

Key points

  • Gut bacteriome and bile-acid patterns are tracked as potential modifiers of androgen metabolism, framed explicitly as a hypothesis.
  • Test to discuss: Total and free testosterone, SHBG, DHEAS
  • Test to discuss: LH, FSH, AMH where indicated
  • Test to discuss: Fasting insulin, glucose, HbA1c
  • Test to discuss: Thyroid and prolactin to exclude mimics
  • Test to discuss: Pelvic ultrasound per criteria
  • Insulin-sensitizing dietary pattern
  • Resistance training
  • Reduce avoidable endocrine-active exposures
  • Early metabolic screening in family history

Root-cause chain

Hyperinsulinemia → Ovarian androgen productionA

B · Established causal · Insulin amplifies LH-driven theca-cell androgen synthesis and lowers SHBG.

Adipose inflammation → Insulin resistanceB

I · Observational association · Cytokine signaling contributes to peripheral insulin resistance in PCOS cohorts.

Endocrine-active exposure (e.g. bisphenols) → Androgen and SHBG alterationC

T · Observational association · Cross-sectional studies report higher urinary bisphenol levels in PCOS; direction of effect is unresolved.

Inositol and vitamin D insufficiency → Ovulatory dysfunctionC

N · Randomized evidence · Small trials report improved ovulatory frequency with myo-inositol; effect sizes vary.

Protocols by lane

Evidence grade + regulatory status
Conventional: Combined hormonal contraceptive for cycle and androgen controlA

First-line for menstrual regulation and hyperandrogenism.

Status: FDA-approved · Cautions: Thrombotic risk; contraindicated in migraine with aura, smoking over 35, prior VTE.

Conventional: Letrozole for ovulation inductionA

Higher live-birth rate than clomiphene in PCOS.

Status: Off-label · Cautions: Requires fertility monitoring; not for use in pregnancy.

Functional: Insulin-sensitizing nutrition and training planB

Improves ovulatory function and metabolic markers.

Status: Lifestyle · Cautions: Avoid restrictive patterns in disordered-eating history.

Orthomolecular: Myo-inositol with D-chiro-inositolC

Modest improvements in ovulation and insulin indices in small trials.

Status: Supplement · Cautions: GI upset; monitor glucose with concurrent insulin sensitizers.

Traditional: Spearmint tea for mild hirsutismE

Small trials report reduced free testosterone.

Status: Supplement · Cautions: Not adequate for significant hyperandrogenism.

Energy / Physical: Acupuncture for cycle regularityD

Trials show no reliable improvement in live birth rate.

Status: Investigational · Cautions: Should not displace ovulation induction when pregnancy is the goal.

Monitoring

  • Cycle regularity log
  • Androgenic symptom score
  • Metabolic panel every 6–12 months

Go deeper

iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.